Reminyl Alzheimer's Treatment Now Oral SolutionSENIOR JOURNAL.COM - Senior Citizens Information and NewsNewest Treatment for Alzheimer's Disease, Reminyl(R), Now Approved as Oral SolutionJune 26, 2001 -- Reminyl® (galantamine hydrobromide) -- the newest treatment for mild to moderate Alzheimer's disease -- has now been approved in an oral-solution formulation by the U.S. Food and Drug Administration (FDA).Reminyl tablets* were approved by the FDA on Feb. 28. This latest action by the agency allows the medication to be available in an alternative form for individuals who prefer to drink a liquid or cannot swallow tablets. It is estimated that nearly 5 million Americans have Alzheimer's disease, the majority of whom are older than 65 and frequently have other medical conditions. Reminyl Oral Solution is expected to be available through pharmacies later this summer.
FOR REMINYL
galantamine lucid dream
